Patents by Inventor Spencer Brian Jones

Spencer Brian Jones has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUBSTITUTED FUSED AZINES AS KRAS G12D INHIBITORS
    Publication number: 20240228511
    Abstract: The present invention provides compounds of the formula where R1, R2, R3, R4a, R4b, R4c, R5, R6, X, Y, and Z are as described herein, pharmaceutically acceptable salts thereof, and methods of using these compounds and pharmaceutically acceptable salts thereof for treating patients for cancer.
    Type: Application
    Filed: June 8, 2022
    Publication date: July 11, 2024
    Inventors: David Anthony BARDA, Joshua Ryan CLAYTON, Jeffry Bernard FRANCISKOVICH, Kelly Wayne FURNESS, Douglas Linn GERNERT, James Robert HENRY, Richard Duane JOHNSTON, Spencer Brian JONES, Jason Eric LAMAR, Adam Marc LEVINSON, Curren Tapfuma MBOFANA, Michael John RODRIQUEZ, Almudena RUBIO, Chong SI, Gaiying ZHAO, Mohammed Sadegh ZIA-EBRAHIMI
  • Imidazo pyridine compounds
    Patent number: 9394317
    Abstract: The present invention provides compounds of the formula I, wherein X is a bond or CH2; Q is CH2 or O; L is selected from the group consisting of —OCH2— and —CH2O—; or a pharmaceutically acceptable salt thereof. Compounds of the invention are autotaxin inhibitors.
    Type: Grant
    Filed: March 4, 2014
    Date of Patent: July 19, 2016
    Assignee: Eli Lilly and Company
    Inventors: Spencer Brian Jones, Bryan Hurst Norman, Lance Allen Pfeifer
  • IMIDAZO PYRIDINE COMPOUNDS
    Publication number: 20150368273
    Abstract: The present invention provides compounds of the formula I, wherein X is a bond or CH2; Q is CH2 or O; L is selected from the group consisting of —OCH2— and —CH2O—; or a pharmaceutically acceptable salt thereof. Compounds of the invention are autotaxin inhibitors.
    Type: Application
    Filed: March 4, 2014
    Publication date: December 24, 2015
    Inventors: Spencer Brian Jones, Bryan Hurst Norman, Lance Allen Pfeifer
  • Bicyclic pyrimidine compounds
    Patent number: 8969555
    Abstract: The present invention provides compounds of the Formula I: wherein X is a bond or CH2; R is selected from the group consisting of R1 and R2 are each independently selected from the group consisting of CH and N; R3 is H or CH3; R4 is H or CH3; L is selected from the group consisting of —O(CH2)3—, —C(O)NH(CH2)2—, —CH2C(O)NH(CH2)2—, —(CH2)3N(C(O)CH3)CH2—, —(CH2)2N(C(O)CH3)CH2—, —(CH2)3NH—, (CH2)2OCH2—, —(CH2)4—, —(CH2)2NHCH2—, —(CH2)3O—, and —CH2O(CH2)2—; or a pharmaceutically acceptable salt thereof. Compounds of this invention are autotaxin inhibitors.
    Type: Grant
    Filed: January 7, 2014
    Date of Patent: March 3, 2015
    Assignee: Eli Lilly and Company
    Inventors: Thomas James Beauchamp, Yen Dao, Spencer Brian Jones, Bryan Hurst Norman, Lance Allen Pfeifer
  • Bicyclic Pyrimidine Compounds
    Publication number: 20140200231
    Abstract: The present invention provides compounds of the Formula I: wherein X is a bond or CH2; R is selected from the group consisting of R1 and R2 are each independently selected from the group consisting of CH and N; R3 is H or CH3; R4 is H or CH3; L is selected from the group consisting of —O(CH2)3—, —C(O)NH(CH2)2—, —CH2C(O)NH(CH2)2—, —(CH2)3N(C(O)CH3)CH2—, —(CH2)2N(C(O)CH3)CH2—, —(CH2)3NH—, (CH2)2OCH2—, —(CH2)4—, —(CH2)2NHCH2—, —(CH2)3O—, and —CH2O(CH2)2—; or a pharmaceutically acceptable salt thereof. Compounds of this invention are autotaxin inhibitors.
    Type: Application
    Filed: January 7, 2014
    Publication date: July 17, 2014
    Applicant: Eli Lilly and Company
    Inventors: Thomas James Beauchamp, Yen Dao, Spencer Brian Jones, Bryan Hurst Norman, Lance Allen Pfeifer